Accepted at 3:41 p.m. May, 10, 2026 by Ahmed7
Author: adavis98
Co-authors: andrewmathias8
Related Note: 1472078824458 1
Rationale for change

Herceptin (trastuzumab) is an anti-neoplastic agent known to cause dilated cardiomyopathy.

This is also referenced by nid:1536685207989

Source: AMBOSS - https://next.amboss.com/us/article/_k05qT?q=trastuzumab#Y4a6901c60b600796b0b9a8f40b23c7aa

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Empty field
Additional Resources
One by one
Empty field
#AK_Step1_v12::#SketchyPharm::08_Antineoplastics::02_DNA_&_Cellular_Division::03_Cytotoxic_Antibiotics #AK_Step2_v12::#Bootcamp::Medicine::01_Cardiology::03_Heart_Failure::04_Cardiomyopathies #AK_Step1_v12::#FirstAid::07_Cardiovascular::04_Pathology::28_Cardiomyopathies::01_Dilated_cardiomyopathy #AK_Other::AnKing_Image::!Subjects::Cardiology::Cardiomyopathies #AK_Step2_v12::#SketchyIM::01_Cardiology::03_Cardiomyopathies_&_Heart_Muscle::01_Dilated_Cardiomyopathy #AK_Step1_v12::#B&B::12_Hematology::04_Cancer_Drugs::03_Antitumor_Antibiotics #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Cardiovascular::Cardio_Pathology #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::03_Doxorubicin/Daunorubicin #AK_Step2_v12::#OME::01_Medicine::01_Cardiology::05_Cardiomyopathy #AK_Step1_v12::#Bootcamp::Cardiology::18_Cardiomyopathy::02_Dilated_Cardiomyopathy #AK_Step2_v12::#UWorld::Step::12085 #AK_Step1_v12::#AMBOSS::v6aA5l #AK_Step1_v12::#UWorld::Step::1014 #AK_Step1_v12::^Systems::Cardio::Pathology #AK_Step1_v12::#Pathoma::08_Cardiac::06_Cardiomyopathy #AK_Step1_v12::#UWorld::COMLEX::26464 #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#NBME::29 #AK_Step2_v12::#Resources_by_rotation::IM::ome::cardio::cardiomyopathy #AK_Step1_v12::#SketchyPath::01_Cardiac::03_Myocardial_&_Pericardial_Disorders::01_Dilated_&_Restrictive_Cardiomyopathy #AK_Step1_v12::#UWorld::Step::15650 #PANCE::CARDIO::cardiomyopathy #AK_Step2_v12::#SketchyIM::01_Cardiology::12_Retired_Lessons::03_Cardiomyopathies_&_Heart_Muscle::01_Dilated_&_Restrictive_Cardiomyopathies_[OLD_VERSION] #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#UWorld::COMLEX::24125 #AK_Step2_v12::#AMBOSS::Ex08yR #AK_Step1_v12::#Physeo::11_Pathology::01_Cardiac_Pathology::12_Cardiomyopathy #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::04_Oncology::03_Hodgkin_Lymphoma_SOAP #AK_Other::AnKing_Image::Mujeeb::Cardiomyopathies #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::11_Cell_Cycle_Independent_Drug_Targets #AK_Step2_v12::#COMBANK::50340 #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::21_Key_chemotoxicities #AK_Step2_v12::#NBME::Form10 #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Cardiology::Cardiomyopathy #AK_Step1_v12::#Textbooks::#Cecil::010_Pericardial_and_Myocardial_Disease #AK_Step1_v12::#Textbooks::#Robbins::12_The_Heart #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield